161 related articles for article (PubMed ID: 8950782)
1. Detection of factor V Leiden from a drop of blood by PCR-SSCP.
Corral J; Iniesta JA; González-Conejero R; Vicente V
Thromb Haemost; 1996 Nov; 76(5):735-7. PubMed ID: 8950782
[TBL] [Abstract][Full Text] [Related]
2. Rapid detection of factor V Leiden (FVQ506) by non-radioactive single strand conformation polymorphism (SSCP).
Arruda VR; von Zuben PM; Annichino-Bizzachi JM; Costa FF
Sangre (Barc); 1996 Oct; 41(5):379-81. PubMed ID: 8986114
[TBL] [Abstract][Full Text] [Related]
3. Phenotyping and genotyping of coagulation factor V Leiden.
Engel H; Zwang L; van Vliet HH; Michiels JJ; Stibbe J; Lindemans J
Thromb Haemost; 1996 Feb; 75(2):267-9. PubMed ID: 8815574
[TBL] [Abstract][Full Text] [Related]
4. Activated protein C resistance--a major risk factor for thrombosis.
Rosén SB; Sturk A
Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous detection of FV Q506 and prothrombin 20210 A variation by allele-specific PCR.
Mitterer M; Lanthaler AJ; Mair W; Giacomuzzi K; Coser P
Haematologica; 1999 Mar; 84(3):204-7. PubMed ID: 10189382
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of a type I quantitative factor V deficiency in a thrombosis patient that is "pseudo homozygous" for activated protein C resistance.
Guasch JF; Lensen RP; Bertina RM
Thromb Haemost; 1997 Feb; 77(2):252-7. PubMed ID: 9157576
[TBL] [Abstract][Full Text] [Related]
7. The prevalence of factor V Leiden as a risk factor for venous thromboembolism in the population of North-Western Greece.
Ioannou HV; Mitsis M; Eleftheriou A; Matsagas M; Nousias V; Rigopoulos C; Vartholomatos G; Kappas AM
Int Angiol; 2000 Dec; 19(4):314-8. PubMed ID: 11305729
[TBL] [Abstract][Full Text] [Related]
8. Detection of the factor V Leiden using SSCP.
Margaglione M; D'Andrea G; Cappucci G; Grandone E; Giuliani N; Colaizzo D; Vecchione G; Di Minno G
Thromb Haemost; 1996 Nov; 76(5):814-5. PubMed ID: 8950796
[No Abstract] [Full Text] [Related]
9. Resistance to activate protein C, the Arg506 to Gln mutation in the factor V gene, and venous thrombosis. Functional tests and DNA-based assays, pros and cons.
Dahlbäck B
Thromb Haemost; 1995 May; 73(5):739-42. PubMed ID: 7482395
[No Abstract] [Full Text] [Related]
10. Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis.
Bertina RM; Reitsma PH; Rosendaal FR; Vandenbroucke JP
Thromb Haemost; 1995 Jul; 74(1):449-53. PubMed ID: 8578504
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of a new functional test for detection of activated protein C resistance (Pefakit APC-R Factor V Leiden) at two centers in Europe and the USA.
Schöni R; Quehenberger P; Wu JR; Wilmer M
Thromb Res; 2007; 119(1):17-26. PubMed ID: 16934314
[TBL] [Abstract][Full Text] [Related]
12. [Activated C protein resistance: laboratory study and prevalence of the defect in the Chilean population].
Pereira J; Quiroga T; Goycoolea M; Muñoz B; Hidalgo P; Kaltwasser G; Mezzano D
Rev Med Chil; 1996 Jun; 124(6):663-8. PubMed ID: 9041721
[TBL] [Abstract][Full Text] [Related]
13. The polymerase chain reaction with sequence specific primers for the detection of the factor V mutation associated with activated protein C resistance.
Kirschbaum NE; Foster PA
Thromb Haemost; 1995 Sep; 74(3):874-8. PubMed ID: 8571314
[TBL] [Abstract][Full Text] [Related]
14. Rapid genotyping of factor V Leiden mutation using single-tube bidirectional allele-specific amplification and automated ultrathin-layer agarose gel electrophoresis.
Sasvari-Szekely M; Gerstner A; Ronai Z; Staub M; Guttman A
Electrophoresis; 2000 Mar; 21(4):816-21. PubMed ID: 10733227
[TBL] [Abstract][Full Text] [Related]
15. Allelic discrimination of factor V Leiden using a 5' nuclease assay.
Happich D; Schwaab R; Hanfland P; Hoernschemeyer D
Thromb Haemost; 1999 Oct; 82(4):1294-6. PubMed ID: 10544916
[TBL] [Abstract][Full Text] [Related]
16. Comparison of an activated partial thromboplastin time with a Russell viper venom time test in screening for factor V(Leiden) (FVR506Q).
Sweeney JD; Blair AJ; King TC
Am J Clin Pathol; 1997 Jul; 108(1):74-7. PubMed ID: 9208981
[TBL] [Abstract][Full Text] [Related]
17. Discrimination between normal wildtype and carriers of coagulation factor V Leiden mutation by the activated protein C resistance test in the presence of factor V deficient plasma.
Reuner KH; Litfin F; Patscheke H
Eur J Clin Chem Clin Biochem; 1997 Jan; 35(1):41-5. PubMed ID: 9156566
[TBL] [Abstract][Full Text] [Related]
18. Improved distinction of factor V wild-type and factor V Leiden using a novel prothrombin-based activated protein C resistance assay.
Wilmer M; Stocker C; Bühler B; Conell B; Calatzis A
Am J Clin Pathol; 2004 Dec; 122(6):836-42. PubMed ID: 15539375
[TBL] [Abstract][Full Text] [Related]
19. Rapid multiplex analysis for the factor V Leiden and prothrombin G20210A mutations associated with hereditary thrombophilia.
Linfert DR; Rezuke WN; Tsongalis GJ
Conn Med; 1998 Sep; 62(9):519-25. PubMed ID: 9785636
[TBL] [Abstract][Full Text] [Related]
20. Factor V Leiden genotyping using real-time fluorescent polymerase chain reaction.
Sanders Sevall J
Mol Cell Probes; 2000 Aug; 14(4):249-53. PubMed ID: 10970729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
